Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
April 10, 2024. Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group Ltd., announced that the US Food and ...
March 25 2024. Simcere Zaiming, the oncology subsidiary of Simcere Pharmaceutical Group Ltd, will present its innovative research at the 2024 American...
On March 19, 2024, Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group Ltd., announced that a Phase 1 cli...
Phase III Clinical Study of Daridorexant Achieved the Full Patient Enrollment in ChinaOn March 15, 2024, the Chinese Phase III clinical study of Darid...